Perseus Biomics selected as EIC 2021 startup champion — Perseus Biomics — Perseus Biomics
Summary
The European Commissions European Innovation Council has selected 65 innovative start-ups and SMEs to receive 363 million of funding for breakthrough innovations.Each company will receive a combination of grant financing and equity investment of up to 17 million to develop and scale up their ground - breaking innovations in healthcare, digital technologies, energy, biotechnology, space and other. With the European Innovation Council we aim to bring Europe to the forefront of innovation and new technologies, by investing in new solutions for the health, environmental and societal challenges we are facing.The companies were selected following a new two-step process, introduced under Horizon Europe. Applications are rigorously assessed by external experts and followed by an interview with a jury of experienced investors and entrepreneurs. Among the companies selected are: None Dutch Sensius BV that developed a thermotherapy system to treat the head and neck cancer without negative side effects; None French Alice & Bob that invented a new type of self-correcting quantum hardware to build the worlds first fault-tolerant commercial quantum computers; None Lithuanian UAB INOVATYVI MEDICINA that developed a smart, sensory, tele - operated robotic system, which allows an endovascular procedure to be performed without exposure to harmful X-rays; None Norwegian Bluegrove AS that introduced the most advanced salmon welfare monitoring and prediction solution to take care of fish welfare.The 65 successful companies are established in 16 countries. In addition to financial support, all projects benefit from a range of Business Acceleration Services that provide access to leading expertise, corporates, investors and ecosystem actors.